Imaging BiometricsIQAIF Gross Margin % is 88.24% as of Dec. 2025, which is 10% below its 10-year median of 97.53. The stock has 3 warning signs investors should review. Among 629 Healthcare Providers & Services companies, Imaging Biometrics ranks better than 96.18% on this metric.
The historical rank and industry rank for Imaging Biometrics's Gross Margin % or its related term are showing as below:
IQAIF'
s Gross Margin % Range Over the Past 10 Years
Min: 78.79 Med: 97.53 Max: 99.63
Current: 93.53
During the past 13 years, the highestGross Margin % of Imaging Biometrics was 99.63%. The lowest was 78.79%. And the median was 97.53%.
IQAIF's Gross Margin % is ranked better than 96.18% of 629
companies
in the Healthcare Providers & Services industry
Industry Median: 40.09
vs IQAIF: 93.53
Imaging Biometrics had a gross margin of 88.24% for the quarter that ended in Dec. 2025 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Imaging Biometrics was -0.40% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Imaging Biometrics had a gross margin of 88.24% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Imaging Biometrics Gross Margin % Related Terms
Imaging Biometrics Gross Margin % Historical Data
* Premium members only.
The historical data trend for Imaging Biometrics's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IQAIF vs VEEV, BTSG, TEM: Gross Margin % Comparison
For the Health Information Services subindustry, Imaging Biometrics's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Imaging Biometrics Gross Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Imaging Biometrics's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Imaging Biometrics's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Imaging Biometrics (IQAIF) has a Gross Margin % of 88.24% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Imaging Biometrics and its competitors. This is 10% below median its historical median of 97.53. Over the past decade, Imaging Biometrics' Gross Margin % has ranged from 78.79 to 99.63. According to the industry distribution chart, Imaging Biometrics ranks #24 out of 629 companies in the Healthcare Providers & Services industry, placing it in the top 3.8%.
Is Imaging Biometrics' Gross Margin % too high?
Imaging Biometrics' current Gross Margin % of 88.24% is 10% below median its 10-year median of 97.53. Over the past 10 years, this metric has ranged from a low of 78.79 to a high of 99.63. The Healthcare Providers & Services industry median Gross Margin % is 40.09. Imaging Biometrics' value of 88.24% is 120.1% above this industry median. Based on the distribution chart, Imaging Biometrics ranks #24 out of 629 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers.
How does Imaging Biometrics' Gross Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Imaging Biometrics ranks #24 out of 629 companies for Gross Margin %. This places Imaging Biometrics in the top 4% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 40.09. Imaging Biometrics' value of 88.24% is 120.1% above this benchmark. Historically, Imaging Biometrics' own Gross Margin % has ranged from 78.79 to 99.63 over the past decade. While the company's 10-year median is 97.53 vs. the industry median of 40.09, Imaging Biometrics has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Healthcare Providers & Services company?
The median Gross Margin % among Healthcare Providers & Services companies is 40.09, based on 629 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Imaging Biometrics's current Gross Margin % of 88.24% is 120.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Imaging Biometrics and its competitors. For the Healthcare Providers & Services industry, the median Gross Margin % is 40.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Imaging Biometrics's current Gross Margin % is 88.24%, which is 10% below median its own 10-year median of 97.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Imaging Biometrics stock overvalued right now?
Imaging Biometrics (IQAIF) has a current Gross Margin % of 88.24%. The stock's GF Value™ is $0.03, compared to a current price of $0.02 — trading 33.3% below its estimated fair value. The current Gross Margin % is 88.24%, which is 10% below median its 10-year median of 97.53 and 120.1% above the Healthcare Providers & Services industry median of 40.09. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Imaging Biometrics (IQAIF), the current Gross Margin % is 88.24% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Imaging Biometrics Ltd formerly, IQ-AI Ltd operates as an investment company. The principal activity of the group is the provision of convenient, cost-effective, and clinical treatments to patients in the field of medical imaging diagnostics, based on technologies. Its geographical segment includes United Kingdom, Switzerland, European Union, and the United States of America and reportable segments are holding company expenses, medical software, Oral GaM and organ-on-a-chip. The company derives a majority of its revenue from the United States of America. It also supplies medical technology solutions and has a neuroimaging product portfolio.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IQAIF has been successfully added to your 